Urodynamic Outcomes in Women with Pelvic Organ Prolapse Assessed using Pelvic Organ Prolapse Quantification: A Prospective Study
Magdoleen Barry , Abdulrahman Bogis , Maysoon Alhaizan , Dana Aldabeeb , Baydaa Alsannan , Ghadeer Al-shaikh
Clinical and Experimental Obstetrics & Gynecology ›› 2025, Vol. 52 ›› Issue (10) : 41533
Urodynamic studies (UDS) are diagnostic tools used to evaluate urinary function and guide the management of conditions such as detrusor overactivity (DO) and urodynamic stress incontinence (USI), both of which significantly affect the quality of life of patients. Despite their clinical importance, comprehensive data on the relationship between these outcomes and pelvic organ support are lacking. Pelvic organ prolapse (POP), commonly assessed using the standardized pelvic organ prolapse quantification (POP-Q) system, is frequently associated with lower urinary tract symptoms (LUTS). This study aimed to determine the correlation between POP-Q classification and UDS findings and to investigate the association of different types of POP with DO and USI.
This prospective observational cohort study encompassed women presenting to or referred to the Urogynecology Clinic at King Saud University Medical City, Riyadh, Saudi Arabia. Consecutively enrolled women underwent comprehensive clinical evaluations, including medical history, pelvic examination using the POP-Q system, and standardized urodynamic testing. Chi-square and analysis of variance (ANOVA) tests were used to examine the correlation between anatomical findings and urodynamic parameters, including bladder capacity, post-void residual (PVR), maximum flow rate (Q-max), flow time, time to maximum flow, first desire to void, and strong desire to void. Statistical significance was defined as p < 0.05. Multiple linear regression (MLR) was used to determine the independent predictors of each UDS diagnosis.
Out of the 153 women included, 127 had POP, among whom 74% experienced USI. The most frequent types of POP were anterior (92.1%) and posterior (91.3 %) vaginal wall prolapses, whereas apical prolapse was less frequent (39.4%). Among those with apical prolapse, a significant correlation was observed with time to maximum flow (p = 0.050), even in the earlier stages. A significant association was observed between anterior prolapse and PVR (p = 0.026). Posterior prolapse was significantly correlated with Q-max (p = 0.014) and flow time (p = 0.046). These findings indicate that some elements obstruct the urine outflow. No significant correlations were observed between the USI or DO and the different stages of apical (p = 0.51; p = 0.60), anterior (p = 0.40; p = 0.80), or posterior prolapse (p = 0.55; p = 0.59). The presence of a history of stress incontinence was associated with a four times greater likelihood of the presence of USI in UDS.
This study showed that different stages and types of POP were linked with certain urodynamic findings, suggesting the presence of partial urine outflow obstruction might occur. These findings indicate complex clinical interactions that require personalized management. Recognizing these associations enables clinicians to tailor individualized interventions, such as pessary use, pelvic floor physical therapy, or surgical correction, based on the affected compartment involved and the urodynamic profile, thereby improving symptom control and patient outcomes.
pelvic organ prolapse / urodynamic study / stress urinary incontinence / detrusor overactivity
| [1] |
Nager CW. Role of urodynamics in the evaluation of urinary incontinence and prolapse. Current Obstetrics and Gynecology Reports. 2013; 2: 139–146. |
| [2] |
National Institute for Health and Care Excellence. (2019) Urinary incontinence and pelvic organ prolapse in women: management , NICE.. Available at: https://www.nice.org.uk/guidance/ng123 (Accessed: 1 January 2025). |
| [3] |
Ghoniem G, Stanford E, Kenton K, Achtari C, Goldberg R, Mascarenhas T, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. International Urogynecology Journal and Pelvic Floor Dysfunction. 2008; 19: 5–33. https://doi.org/10.1007/s00192-007-0495-5. |
| [4] |
Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourology and Urodynamics. 2010; 29: 213–240. https://doi.org/10.1002/nau.20870. |
| [5] |
Ghanbari Z, Ghaemi M, Shafiee A, Jelodarian P, Hosseini RS, Pouyamoghaddam S, et al. Quality of Life Following Pelvic Organ Prolapse Treatments in Women: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11: 7166. https://doi.org/10.3390/jcm11237166. |
| [6] |
Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstetrics and Gynecology. 2014; 123: 141–148. https://doi.org/10.1097/AOG.0000000000000057. |
| [7] |
Walker GJA, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. International Urogynecology Journal. 2011; 22: 127–135. https://doi.org/10.1007/s00192-010-1215-0. |
| [8] |
Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300: 1311–1316. https://doi.org/10.1001/jama.300.11.1311. |
| [9] |
Hadizadeh-Talasaz Z, Khadivzadeh T, Mohajeri T, Sadeghi M. Worldwide Prevalence of Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health. 2024; 53: 524–538. https://doi.org/10.18502/ijph.v53i3.15134. |
| [10] |
Wang B, Chen Y, Zhu X, Wang T, Li M, Huang Y, et al. Global burden and trends of pelvic organ prolapse associated with aging women: An observational trend study from 1990 to 2019. Frontiers in Public Health. 2022; 10: 975829. https://doi.org/10.3389/fpubh.2022.975829. |
| [11] |
Al-Badr A, Saleem Z, Kaddour O, Almosaieed B, Dawood A, Al-Tannir M, et al. Prevalence of pelvic floor dysfunction: a Saudi national survey. BMC Women’s Health. 2022; 22: 27. https://doi.org/10.1186/s12905-022-01609-0. |
| [12] |
Malaekah H, Al Medbel HS, Al Mowallad S, Al Asiri Z, Albadrani A, Abdullah H. Prevalence of pelvic floor dysfunction in women in Riyadh, Kingdom of Saudi Arabia: A cross-sectional study. Women’s Health (London, England). 2022; 18: 17455065211072252. https://doi.org/10.1177/17455065211072252. |
| [13] |
Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. American Journal of Obstetrics and Gynecology. 2001; 185: 1332–1337. https://doi.org/10.1067/mob.2001.119078. |
| [14] |
Blain G, Dietz HP. Symptoms of female pelvic organ prolapse: correlation with organ descent in women with single compartment prolapse. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 2008; 48: 317–321. https://doi.org/10.1111/j.1479-828X.2008.00872.x. |
| [15] |
Barbier H, Carberry CL, Karjalainen PK, Mahoney CK, Galán VM, Rosamilia A, et al. International Urogynecology consultation chapter 2 committee 3: the clinical evaluation of pelvic organ prolapse including investigations into associated morbidity/pelvic floor dysfunction. International Urogynecology Journal. 2023; 34: 2657–2688. https://doi.org/10.1007/s00192-023-05629-8. |
| [16] |
Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric: the Journal of the International Menopause Society. 2019; 22: 217–222. https://doi.org/10.1080/13697137.2018.1543263. |
| [17] |
Przydacz M, Golabek T, Dudek P, Lipinski M, Chlosta P. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. Scientific Reports. 2020; 10: 19819. https://doi.org/10.1038/s41598-020-76846-0. |
| [18] |
Harvey MA, Chih HJ, Geoffrion R, Amir B, Bhide A, Miotla P, et al. International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain. International Urogynecology Journal. 2021; 32: 2575–2594. https://doi.org/10.1007/s00192-021-04941-5. |
| [19] |
Cameron AP. Systematic review of lower urinary tract symptoms occurring with pelvic organ prolapse. Arab Journal of Urology. 2019; 17: 23–29. https://doi.org/10.1080/2090598X.2019.1589929. |
| [20] |
Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging. Journal of Medicine and Life. 2011; 4: 75–81. |
| [21] |
Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourology and Urodynamics. 2002; 21: 261–274. https://doi.org/10.1002/nau.10066. |
| [22] |
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. American Journal of Obstetrics and Gynecology. 2002; 186: 1160–1166. https://doi.org/10.1067/mob.2002.123819. |
| [23] |
Munno GM, La Verde M, Lettieri D, Nicoletti R, Nunziata M, Fasulo DD, et al. Pelvic Organ Prolapse Syndrome and Lower Urinary Tract Symptom Update: What’s New? Healthcare (Basel, Switzerland). 2023; 11: 1513. https://doi.org/10.3390/healthcare11101513. |
| [24] |
Schimpf MO, O’Sullivan DM, LaSala CA, Tulikangas PK. Anterior vaginal wall prolapse and voiding dysfunction in urogynecology patients. International Urogynecology Journal and Pelvic Floor Dysfunction. 2007; 18: 721–725. https://doi.org/10.1007/s00192-006-0227-2. |
| [25] |
Bai SW, Kang SH, Kim SK, Kim JY, Park KH. The effect of pelvic organ prolapse on lower urinary tract function. Yonsei Medical Journal. 2003; 44: 94–98. https://doi.org/10.3349/ymj.2003.44.1.94. |
| [26] |
Serati M, Salvatore S, Siesto G, Cattoni E, Braga A, Sorice P, et al. Urinary symptoms and urodynamic findings in women with pelvic organ prolapse: is there a correlation? Results of an artificial neural network analysis. European Urology. 2011; 60: 253–260. https://doi.org/10.1016/j.eururo.2011.03.010. |
| [27] |
Smith FJ, Holman CDJ, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstetrics and Gynecology. 2010; 116: 1096–1100. https://doi.org/10.1097/AOG.0b013e3181f73729. |
/
| 〈 |
|
〉 |